
Christian C. Boesen
Examiner (ID: 11099, Phone: (571)270-1321 , Office: P/1639 )
| Most Active Art Unit | 1639 |
| Art Unit(s) | 1675, 4131, 1684, 1636, 1639 |
| Total Applications | 995 |
| Issued Applications | 678 |
| Pending Applications | 90 |
| Abandoned Applications | 262 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18102446
[patent_doc_number] => 11542321
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-03
[patent_title] => Engineered stable CH2 polypeptides
[patent_app_type] => utility
[patent_app_number] => 16/495245
[patent_app_country] => US
[patent_app_date] => 2018-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9063
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16495245
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/495245 | Engineered stable CH2 polypeptides | Mar 19, 2018 | Issued |
Array
(
[id] => 13566425
[patent_doc_number] => 20180334760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-22
[patent_title] => GENERATION OF LIBRARY OF SOLUBLE RANDOM POLYPEPTIDES LINKED TO mRNA
[patent_app_type] => utility
[patent_app_number] => 15/922759
[patent_app_country] => US
[patent_app_date] => 2018-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5991
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15922759
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/922759 | GENERATION OF LIBRARY OF SOLUBLE RANDOM POLYPEPTIDES LINKED TO mRNA | Mar 14, 2018 | Abandoned |
Array
(
[id] => 13413759
[patent_doc_number] => 20180258422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-13
[patent_title] => SYSTEMS AND METHODS FOR MASSIVELY PARALLEL COMBINATORIAL ANALYSIS OF SINGLE CELLS
[patent_app_type] => utility
[patent_app_number] => 15/920092
[patent_app_country] => US
[patent_app_date] => 2018-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28391
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15920092
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/920092 | Systems and methods for massively parallel combinatorial analysis of single cells | Mar 12, 2018 | Issued |
Array
(
[id] => 16650203
[patent_doc_number] => 10927368
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-23
[patent_title] => Library-based methods and compositions for introducing molecular switch functionality into protein affinity reagents
[patent_app_type] => utility
[patent_app_number] => 15/886271
[patent_app_country] => US
[patent_app_date] => 2018-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 42
[patent_no_of_words] => 19030
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15886271
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/886271 | Library-based methods and compositions for introducing molecular switch functionality into protein affinity reagents | Jan 31, 2018 | Issued |
Array
(
[id] => 16642432
[patent_doc_number] => 10920273
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-16
[patent_title] => Compositions and methods for immune repertoire sequencing
[patent_app_type] => utility
[patent_app_number] => 15/873862
[patent_app_country] => US
[patent_app_date] => 2018-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 12
[patent_no_of_words] => 69482
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 440
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15873862
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/873862 | Compositions and methods for immune repertoire sequencing | Jan 16, 2018 | Issued |
Array
(
[id] => 15574467
[patent_doc_number] => 10577600
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-03
[patent_title] => Surface anchored light chain bait antibody display system
[patent_app_type] => utility
[patent_app_number] => 15/866829
[patent_app_country] => US
[patent_app_date] => 2018-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12308
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15866829
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/866829 | Surface anchored light chain bait antibody display system | Jan 9, 2018 | Issued |
Array
(
[id] => 16215348
[patent_doc_number] => 10731148
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-04
[patent_title] => Use of lambda-gam protein in ribosomal display technology
[patent_app_type] => utility
[patent_app_number] => 15/867471
[patent_app_country] => US
[patent_app_date] => 2018-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 16424
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15867471
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/867471 | Use of lambda-gam protein in ribosomal display technology | Jan 9, 2018 | Issued |
Array
(
[id] => 16991801
[patent_doc_number] => 20210230221
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => PROTEIN THERAPEUTICS FOR TREATMENT OF SENESCENT CELLS
[patent_app_type] => utility
[patent_app_number] => 16/474893
[patent_app_country] => US
[patent_app_date] => 2018-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38568
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16474893
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/474893 | PROTEIN THERAPEUTICS FOR TREATMENT OF SENESCENT CELLS | Jan 2, 2018 | Abandoned |
Array
(
[id] => 16354395
[patent_doc_number] => 10794901
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-06
[patent_title] => Quantitative ligandomics for systematic identification of therapeutic ligands
[patent_app_type] => utility
[patent_app_number] => 15/860170
[patent_app_country] => US
[patent_app_date] => 2018-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 6724
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15860170
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/860170 | Quantitative ligandomics for systematic identification of therapeutic ligands | Jan 1, 2018 | Issued |
Array
(
[id] => 13345801
[patent_doc_number] => 20180224440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-09
[patent_title] => ANTIBODY SCREENING METHODS
[patent_app_type] => utility
[patent_app_number] => 15/847203
[patent_app_country] => US
[patent_app_date] => 2017-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7983
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15847203
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/847203 | Antibody screening methods | Dec 18, 2017 | Issued |
Array
(
[id] => 12754108
[patent_doc_number] => 20180143203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-24
[patent_title] => Fibronectin Type III Repeat Based Protein Scaffolds with Alternative Binding Surfaces
[patent_app_type] => utility
[patent_app_number] => 15/845657
[patent_app_country] => US
[patent_app_date] => 2017-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14542
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15845657
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/845657 | Fibronectin type III repeat based protein scaffolds with alternative binding surfaces | Dec 17, 2017 | Issued |
Array
(
[id] => 15756231
[patent_doc_number] => 10620219
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-14
[patent_title] => Use of nanoexpression to interrogate antibody repertoires
[patent_app_type] => utility
[patent_app_number] => 15/840142
[patent_app_country] => US
[patent_app_date] => 2017-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16992
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15840142
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/840142 | Use of nanoexpression to interrogate antibody repertoires | Dec 12, 2017 | Issued |
Array
(
[id] => 13400739
[patent_doc_number] => 20180251912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-06
[patent_title] => LIBRARIES OF GENETIC PACKAGES COMPRISING NOVEL HC CDR3 DESIGNS
[patent_app_type] => utility
[patent_app_number] => 15/836230
[patent_app_country] => US
[patent_app_date] => 2017-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26769
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15836230
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/836230 | Libraries of genetic packages comprising novel HC CDR3 designs | Dec 7, 2017 | Issued |
Array
(
[id] => 17330881
[patent_doc_number] => 11221339
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-11
[patent_title] => Mapping protein binding sites and conformational epitopes using cysteine labelling and surface display library
[patent_app_type] => utility
[patent_app_number] => 16/467229
[patent_app_country] => US
[patent_app_date] => 2017-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 16
[patent_no_of_words] => 13608
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16467229
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/467229 | Mapping protein binding sites and conformational epitopes using cysteine labelling and surface display library | Dec 7, 2017 | Issued |
Array
(
[id] => 15178259
[patent_doc_number] => 20190359721
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-28
[patent_title] => ANTIGEN-BINDING DOMAIN, AND POLYPEPTIDE INCLUDING CONVEYING SECTION
[patent_app_type] => utility
[patent_app_number] => 16/463222
[patent_app_country] => US
[patent_app_date] => 2017-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50330
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16463222
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/463222 | Antigen-binding domain, and polypeptide including conveying section | Nov 27, 2017 | Issued |
Array
(
[id] => 16111647
[patent_doc_number] => 20200207846
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => LIGAND-BINDING MOLECULE HAVING ADJUSTABLE LIGAND BINDING ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 16/463218
[patent_app_country] => US
[patent_app_date] => 2017-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40727
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16463218
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/463218 | Ligand-binding molecule having adjustable ligand binding activity | Nov 27, 2017 | Issued |
Array
(
[id] => 12862378
[patent_doc_number] => 20180179300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-28
[patent_title] => GENERATION OF BINDING MOLECULES
[patent_app_type] => utility
[patent_app_number] => 15/821502
[patent_app_country] => US
[patent_app_date] => 2017-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19188
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 244
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15821502
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/821502 | Generation of binding molecules | Nov 21, 2017 | Issued |
Array
(
[id] => 15178691
[patent_doc_number] => 20190359937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-28
[patent_title] => CHIMERIC RECEPTORS, BIOSENSOR HOST CELLS AND METHODS/USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/461772
[patent_app_country] => US
[patent_app_date] => 2017-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42359
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16461772
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/461772 | CHIMERIC RECEPTORS, BIOSENSOR HOST CELLS AND METHODS/USES THEREOF | Nov 16, 2017 | Abandoned |
Array
(
[id] => 13342919
[patent_doc_number] => 20180222999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-09
[patent_title] => HUMANIZED ANTIBODIES
[patent_app_type] => utility
[patent_app_number] => 15/801251
[patent_app_country] => US
[patent_app_date] => 2017-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 80714
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15801251
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/801251 | Humanized antibodies | Oct 31, 2017 | Issued |
Array
(
[id] => 15697169
[patent_doc_number] => 10604753
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-31
[patent_title] => Focused libraries of genetic packages
[patent_app_type] => utility
[patent_app_number] => 15/797927
[patent_app_country] => US
[patent_app_date] => 2017-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31927
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 372
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15797927
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/797927 | Focused libraries of genetic packages | Oct 29, 2017 | Issued |